-$0.32 EPS Expected for Calyxt Inc (NASDAQ:CLXT) This Quarter

Analysts expect Calyxt Inc (NASDAQ:CLXT) to announce ($0.32) earnings per share for the current quarter, according to Zacks. Zero analysts have issued estimates for Calyxt’s earnings. Calyxt posted earnings of ($0.26) per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 23.1%. The company is scheduled to issue its next earnings report on Monday, March 9th.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

According to Zacks, analysts expect that Calyxt will report full-year earnings of ($1.11) per share for the current financial year, with EPS estimates ranging from ($1.13) to ($1.08). For the next fiscal year, analysts expect that the company will report earnings of ($1.03) per share, with EPS estimates ranging from ($1.05) to ($1.01). Zacks’ EPS calculations are an average based on a survey of sell-side research firms that cover Calyxt.

Calyxt (NASDAQ:CLXT) last issued its earnings results on Wednesday, November 6th. The company reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.31) by ($0.01). The firm had revenue of $2.97 million during the quarter. Calyxt had a negative return on equity of 36.21% and a negative net margin of 5,509.93%.

A number of analysts recently weighed in on the stock. Zacks Investment Research lowered shares of Calyxt from a “buy” rating to a “hold” rating in a research report on Friday, October 18th. BMO Capital Markets reduced their price objective on shares of Calyxt to $15.00 and set an “outperform” rating on the stock in a research report on Friday. BidaskClub raised shares of Calyxt from a “strong sell” rating to a “sell” rating in a research report on Thursday, September 12th. Finally, National Securities reissued a “buy” rating and issued a $28.00 price objective (down from $35.00) on shares of Calyxt in a research report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $18.25.

Calyxt stock traded down $0.28 during mid-day trading on Friday, hitting $4.05. The stock had a trading volume of 414,300 shares, compared to its average volume of 67,574. The company has a current ratio of 15.96, a quick ratio of 15.94 and a debt-to-equity ratio of 0.23. Calyxt has a one year low of $3.83 and a one year high of $19.30. The firm has a market capitalization of $158.09 million, a P/E ratio of -4.45 and a beta of 2.41. The firm’s 50 day moving average is $5.10 and its 200 day moving average is $9.60.

A number of hedge funds have recently modified their holdings of the business. California Public Employees Retirement System grew its stake in Calyxt by 7.8% in the 3rd quarter. California Public Employees Retirement System now owns 94,401 shares of the company’s stock worth $532,000 after acquiring an additional 6,801 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. grew its stake in Calyxt by 8.6% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 573,323 shares of the company’s stock worth $3,234,000 after acquiring an additional 45,541 shares in the last quarter. Nikko Asset Management Americas Inc. grew its stake in Calyxt by 8.6% in the 3rd quarter. Nikko Asset Management Americas Inc. now owns 573,323 shares of the company’s stock worth $3,234,000 after acquiring an additional 45,541 shares in the last quarter. Essex Investment Management Co. LLC grew its stake in Calyxt by 91.4% in the 3rd quarter. Essex Investment Management Co. LLC now owns 22,436 shares of the company’s stock worth $127,000 after acquiring an additional 10,716 shares in the last quarter. Finally, River & Mercantile Asset Management LLP bought a new position in Calyxt in the 2nd quarter worth about $146,000. Institutional investors and hedge funds own 28.19% of the company’s stock.

About Calyxt

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes.

See Also: Google Finance Portfolio Workaround

Get a free copy of the Zacks research report on Calyxt (CLXT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Calyxt (NASDAQ:CLXT)

Leave a Reply

Your email address will not be published. Required fields are marked *

*